NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

電子皮膚貼片 2021-2031年

Electronic Skin Patches 2021-2031

出版商 IDTechEx Ltd. 商品編碼 1015121
出版日期 內容資訊 英文 503 Slides
商品交期: 最快1-2個工作天內
價格
電子皮膚貼片 2021-2031年 Electronic Skin Patches 2021-2031
出版日期: 2021年06月23日內容資訊: 英文 503 Slides
簡介

標題
電子皮膚貼片2021-2031年
對靈活、可穿戴、智能皮膚貼片商業化的最全面評估。

"到 2031 年,電子皮膚貼片市場價值每年將超過 300 億美元。"

這份報告描述了電子皮膚貼片的市場、技術和參與者。涵蓋28 個應用領域和 127 家公司,2010-2020 年的歷史市場數據和 2021-2031 年的市場預測,是針對該產品領域編製的最全面的研究。它揭示了重大機遇,到 2021 年該行業的電子皮膚貼片年收入將超過 100 億美元,預計到 2031 年這一數字將增長到 300 億美元以上。

皮膚貼片是貼在皮膚上的可穿戴產品。電子元件涉及傳感器、執行器、處理器和通信等電子功能的集成,使產品變得連接和 "智能" 。在許多方面,皮膚貼片充當最終的可穿戴電子設備,以最小的負擔和最大的舒適度增強佩戴者的能力。因此,從 2014 年開始,人們對電子皮膚貼片的興趣飆升,這是圍繞 "可穿戴設備" 的重大炒作和市場增長的副產品。

然而,該行業內的一些產品類型超越了這種炒作。一些皮膚貼片產品,特別是在糖尿病管理、心血管監測和其他生命體徵監測方面,已經取代了成熟市場中的現有選擇,每年為處於這一浪潮最前沿的公司創造數十億美元的新收入。然而,成功並非無處不在。本報告中討論的每個市場都位於一個獨特的生態系統中,具有不同的參與者、驅動因素、限制和歷史。

因此,該報告依次審視了電子皮膚貼片的每個應用領域,討論了相關技術、產品類型、競爭格局、行業參與者、定價、歷史收入和市場預測。涵蓋的領域包括糖尿病管理、心血管監測設備(MCT、Holter 監測器、事件監測器和相關產品)、醫療患者監測(住院和門診)、運動傳感、溫度傳感、藥物和化妝品輸送貼片、電刺激設備、智能傷口護理等新興選擇。該報告包含回溯到 2010 年研究的每個產品部門的歷史收入數據,包括公司針對較大部門的數據。該報告還包含對每個關鍵應用領域10 年以上的詳細市場預測。

報告中討論的 28 個應用領域
來源 IDTechEx

"電子皮膚貼片" 的產品類別隱藏了大量的多樣性。雖然許多人可能將皮膚貼片想像成貼近皮膚的薄型、高度貼合的設備,但現實是,當今許多最成功的產品仍然是相對笨重的設備。因此,報告中的每一章還包含對與智能貼片未來發展相關的技術領域的討論,特別是圍繞柔性、可拉伸和保形電子元件等領域。這些技術的發展不僅將使更多產品能夠部署為皮膚貼片,而且還將改進現有電子皮膚貼片的外形。IDTechEx 在柔性電子、可拉伸電子、薄型和柔性電池、智能紡織品和其他相關主題等主題中的其他工作中也廣泛涵蓋了這一點。

該報告背後的研究由 IDTechEx 分析師經過數年編製而成。它遵循現有的可穿戴技術、柔性電子、可拉伸和保形電子、電子紡織品、高級傷口護理、生物電子、傳感器和其他醫療設備等領域的覆蓋範圍。該方法涉及初級和次級研究的混合,重點是與來自開發商業電子皮膚貼片的公司的高管和科學家交談。因此,該報告彙編了 127 家公司和項目的案例研究,每個公司和項目都會隨著時間的推移進行更新,並在相應的產品生態系統中進行比較。

來源 IDTechEx

報告背後的獨特立場和經驗

IDTechEx在涵蓋該主題方面享有特別獨特的地位。經驗豐富的分析師團隊以數十年的經驗為基礎,涵蓋新興技術市場,尤其是柔性電子等領域,這些領域是電子皮膚貼片的核心。IDTechEx 在組織涵蓋柔性和可穿戴電子產品的領先行業會議和展覽以及涵蓋特定創新趨勢(例如醫療傳感器或相關領域)的小型活動方面的平行活動歷來支持這一點。IDTechEx 具有在這些主題領域中策劃網絡的獨特能力,從而促進本報告中的報告。

來自 IDTechEx 的分析師訪問

購買所有報告都包括與專家分析師進行長達 30 分鐘的電話通話,他將幫助您將報告中的關鍵發現與您要解決的業務問題聯繫起來。這需要在購買報告後的三個月內使用。

目錄

1. 執行摘要

  • 1.1. 執行介紹:電子皮膚貼
  • 1.2. 應用概述
  • 1.3. 應用、市場規模和前景
  • 1.4. 糖尿病管理生態系統
  • 1.5。CGM引領潮流
  • 1.6. 胰島素泵和貼片泵
  • 1.7。糖尿病管理的前景
  • 1.8。通過皮膚貼片監測心臟
  • 1.9. 心臟監測的參與者和產品類型
  • 1.10. 心臟監測皮膚貼片:歷史數據:2010-2020
  • 1.11. 心臟監測皮膚貼片:市場預測
  • 1.12。通用設備的應用潛力
  • 1.13. 歷史市場數據,2010-2020
  • 1.14. 2021-2031 年市場預測
  • 1.15。皮膚貼片溫度傳感:跨越 13 個案例研究的用例
  • 1 .16。主要結論:感溫皮膚貼片
  • 1.17. 電刺激產品類型
  • 1.18. 生物電子醫學中的皮膚貼片
  • 1.19. 通過皮膚貼片進行電刺激:市場數據(2010-2019)
  • 1.20。通過皮膚貼片進行電刺激:市場預測(2021-2031)
  • 1.21. 通過皮膚貼片進行離子導入:市場數據(2010-2019)
  • 1.22。通過皮膚貼片進行離子導入:市場預測(2020-2030)
  • 1.23。主要結論:離子電滲療法
  • 1.24。考試案例研究的選手普萊斯

2. 簡介

  • 2.1.1. 皮膚貼片案例:增強人體
  • 2.1.2. 皮膚貼片案例:改進設備外形
  • 2.1.3. 定義和排除
  • 2 .1.4. 皮膚貼片的歷史
  • 2.1.5. 應用、市場規模和前景
  • 2.1.6. 報銷推動商業商業模式
  • 2.1.7. 專利:按受讓人劃分的有效專利總數
  • 2.1.8。專利隨著時間的推移
  • 2.1.9。專利:受讓人的活躍和強大的專利
  • 2.1.10。背景:可穿戴設備炒作
  • 2.1.11。詞彙表
  • 2.1.12。詞彙表(續)
  • 2.2. 應用概述
    • 2.2.1. 與成熟產品競爭的皮膚貼劑
    • 2.2.2. 圍繞皮膚補丁創建新標記
    • 2.2.3. 欄目內容

3. 通過皮膚貼片進行糖尿病管理

  • 3.1.1. 背景:糖尿病簡介
  • 3.1.2. 糖尿病患病率
  • 3.1.3. 背景:糖尿病呈上升趨勢
  • 3.1.4. 背景:糖尿病的成本
  • 3.1.5。背景:糖尿病管理過程
  • 3.1.6。糖尿病管理生態系統
  • 3.1.7。糖尿病管理設備路線圖:總結
  • 3.1.8。糖尿病管理設備路線圖:傳感器
  • 3.1.9。本報告的覆蓋範圍
  • 3.2. 連續血糖監測 (CGM)
    • 3.2.1. 連續血糖監測 (CGM) 案例
    • 3.2.2. 典型 CGM 設備的剖析
    • 3.2.3. CGM 通過皮膚補丁部署
    • 3.2.4. CGM 設備的比較指標
    • 3.2.5. 示例:CGM 設備隨時間變化的準確性
    • 3.2.6. CGM:技術
    • 3.2.7. CGM 傳感器化學
    • 3.2.8。感應燈絲結構
  • 3.3. CGM:主要參與者概述
    • 3.3.1. CGM:主要參與者概述
    • 3.3.2. 雅培實驗室:簡介
    • 3.3.3. 雅培實驗室:CGM 業務
    • 3.3.4. 雅培:自由泳R 自由
    • 3.3.5. 雅培: "有線□"
    • 3.3.6. 雅培:設備和傳感器結構
    • 3.3.7。Dexcom:介紹
    • 3.3.8。Dexcom:CGM 產品
    • 3.3.9。Dexcom:傳感器結構
    • 3.3.10。美敦力:簡介
    • 3.3.11。美敦力:糖尿病和 CGM 業務
    • 3.3.12。美敦力:傳感器結構
    • 3.3.13。美敦力:走向閉環
    • 3.3.14。美敦力:CGM 專利
    • 3.3.15。羅氏:概述
    • 3.3.16。羅氏:CGM 專利
    • 3.3.17。感覺學
    • 3.3.18。Ascensia & POCTech
    • 3.3.19。中通
    • 3.3.20。Medtrum:CGM 設備和胰島素泵
    • 3.3.21。Medtrum:傳感技術
    • 3.3.22。Medtrum:人造胰腺的具體發展步驟
    • 3.3.23。中通
    • 3.3.24。Aga矩陣和波形技術
    • 3.3.25。英飛凌
    • 3.3.26。PK活力
    • 3.3.27。佐野
    • 3.3.28。Verily/Google:隱形眼鏡
  • 3.4. 無創血糖監測
    • 3.4.1. 背景:葡萄糖在微博DY
    • 3.4.2. 用於葡萄糖監測的不同分析物的評估
    • 3.4.3. 評估準確性的關鍵標準
    • 3.4.4. 背景:FDA 要求
    • 3.4.5。無創血糖監測方法
    • 3.4.6. 使用每種技術的公司
    • 3.4.7。使用每種技術(其他流體)的公司
    • 3.4.8。無創血糖監測何時商業化?
    • 3.4.9。非侵入性血糖監測的著名引述
  • 3.5。胰島素deliv ERY
    • 3.5.1. 胰島素輸送:介紹
    • 3.5.2. 糖尿病管理設備路線圖:胰島素輸送
    • 3.5.3. 胰島素泵:介紹
    • 3.5.4. 目前可用的胰島素泵
    • 3.5.5。胰島素泵故障
    • 3.5.6。胰島素貼片泵
    • 3.5.7。示例:Medtronic 的貼片泵?
    • 3.5.8。貼片泵與傳統選項的定價模型
    • 3.5.9。胰島素泵市場
    • 3.5.10。胰島素泵參與者和市場份額
    • 3.5.1 1. 市場:貼片泵與傳統輸液泵
    • 3.5.12。比較胰島素泵和 CGM
    • 3.5.13。胰島素泵的前景
  • 3.6. 連接胰島素泵和 CGM:走向閉環和人工胰腺
      <李>3.6.1。今天:混合閉環系統
    • 3.6.2. 示例:美敦力的進展
    • 3.6.3. 目標:關閉反饋迴路
    • 3.6.4. 例子和夥伴關係
    • 3.6.5。示例:DiabeLoop
    • 3.6.6。Medtrum:致力於人造胰腺
  • 3.7. 市場數據:歷史和預測
    • 3.7.1. 皮膚斑塊和糖尿病:預測摘要
    • 3.7.2. 概述:2020 年 CGM 市場份額和參與者
    • 3.7.3. 糖尿病管理的重點轉移,歷史數據:2010-2020
    • 3.7.4。試紙業務下滑
    • 3.7.5。CGM增長加速
    • 3.7.6。胰島素泵市場
    • 3.7.7。市場:貼片泵與傳統輸液泵
    • 3.7.8。孔定量糖尿病和CGM對準焦點預測
    • 3.7.9。構建自上而下的預測場景
    • 3.7.10。CGM:市場預測(收入)
    • 3.7.11。CGM:市場預測(銷量)
    • 3.7.12。胰島素泵:市場預測(收入)
    • 3.7.13。胰島素泵:市場預測(銷量)
    • 3.7.14。完整數據集:糖尿病管理中的皮膚斑塊,2010-2020(歷史)和 2021-2031(預測)
    • 3.7.15。完整數據集:糖尿病管理市場,2010-2020(歷史)和 2021-2 031(預測)

4. 一般患者監測:生命體徵和相關指標

  • 4.1. 介紹
    • 4.1.1. 介紹
    • 4.1.2. 皮膚貼片的驅動因素和要求
    • 4.1.3. 通用設備的應用潛力
    • 4.1.4. 通用監控設備的部署挑戰
    • 4.1.5. 隨著時間的推移不斷發展的市場動態
    • 4.1.6。一般監控需要一個只有較大的參與者才能提供的基礎設施
    • 4.1.7。歷史市場數據,2010-2020
    • 4.1.8。2021-2031 年市場預測
  • 4.2. 住院監護
    • 4.2.1. 傳統住院監護
    • 4.2.2. 拆線盒
    • 4.2.3. 新興的皮膚補丁選項
    • 4.2.4. 玩家和方法
    • 4.2.5. 飛利浦
    • 4.2.6. 生物智能感知
    • 4.2.7. 萬歲
    • 4.2.8. 外科公司(前身為 Sensium)
    • 4.2.9. 重要連接
    • 4.2.10。Isansys 生活護理 <我>4.2.11。無線住院監護的市場數據和預測
  • 4.3. 用皮膚貼片進行門診監測
    • 4.3.1. 介紹
    • 4.3.2. 生命信號
    • 4.3.3. 三星
    • 4.3.4. MC10
    • 4.3.5. DevIn nova/Scaleo Medical
    • 4.3.6. 艾凡尼克斯
    • 4.3.7。Avanix - 商業模式和目標里程碑
    • 4.3.8。歷史:高通生活
    • 4.3.9。Qualcomm Life/Capsule Technologies
    • 4.3.10。無線門診監測的市場數據和預測

5. 心血管監測皮膚貼片

  • 5.1.1. 簡介 - 通過可穿戴設備進行心血管監測
  • 5.1.2. 簡介 - 測量生物電勢
  • 5.1.3. 技術概述 -測量生物電勢的電路
  • 5.1.4. 簡介 - 心電圖(ECG 或 EKG)
  • 5.1.5。心臟監測設備
  • 5.1.6。心臟監測設備類型 - 皮膚貼片
  • 5.1.7。公司和產品類型
  • 5.1.8 . 技術概覽 - 電極特性
  • 5.1.9。一次性 Ag/AgCl 電極
  • 5.1.10。電極:傳統方法
  • 5.1.11。帶一次性電極的皮膚貼片
  • 5.1.12。帶有集成電極的皮膚貼片
  • 5.2. 報銷
    • 5.2.1. 可穿戴心臟監護儀的報銷代碼
    • 5.2.2. 2021 年:新的報銷結構到位
    • 5.2.3. 2021 年代碼更改後的影響和展望
  • 5.3. 球員
    • 5 .3.1. 對 20 位行業參與者的總結和訪談
    • 5.3.2. 飛利浦
    • 5.3.3. 生物遙測公司
    • 5.3.4. 生物遙測:時間軸
    • 5.3.5。節奏
    • 5.3.6. 斯科特關懷
    • 5.3.7。福田電子
    • 5.3.8。籐田醫療器械
    • 5.3.9。比特
    • 5.3.10。Byteflies 和 Quad Industries
    • 5.3.11。心電圖
    • 5.3.12。維沃米
    • 5.3.13。昆騰醫療
    • 5.3.14。西南醫療
    • 5.3.15。SWMedical - CardiNova
    • 5.3.16。賽思科技
    • 5.3.17。根蒂
    • 5.3.18。預防解決方案
    • 5.3.19。知道
    • 5.3.20。博薩姆
    • 5.3.21。皮質
    • 5.3.22。卡迪奧
    • 5.3.23。卡迪奧 (2)
    • 5.3.24。霍爾斯特中心:皮膚補丁
    • 5.3.25。打點
    • 5.3.2 6. Mezoo
    • 5.3.27。水明
    • 5.3.28。美敦力:SEEQ MCT(已停產)
    • 5.3.29。LumiraDx/FitLinxx:Ampstrip(已停產)
  • 5.4. 與其他形式因素的競爭
    • 5.4.1. 用於動態心臟監測的其他形式因素
    • 5.4.2. 可穿戴與植入式監測
    • 5.4.3. 示例:美敦力 (SEEQ & LINQ)
    • 5.4.4. 比較:胸帶
    • 5.4.5。比較:服裝
    • 5.4.6. 比較:便攜式設備
    • 5.4.7。COM型坯:Smartwatch可光HRM
  • 5.5。市場數據和預測
    • 5.5.1. 市場概況和預測
    • 5.5.2. COVID-19 的影響
    • 5.5.3. 心臟監測皮膚貼片:歷史數據:2010-2020
    • 5.5.4。心臟監測皮膚貼片:市場預測
    • 5.5.5。帶錶的完整數據集:2010-2019(歷史)和 2020-2030(預測)
    • 5.5.6。主要結論:心臟監測皮膚貼片

6. 胎兒心率監測

  • 6.1. 胎兒監護
  • 6.2. 莫妮卡醫療保健
  • 6.3. 通用電氣醫療
  • 6.4. 飛利浦
  • 6.5。主要結論和市場數據

7. 溫度感應皮膚貼片

  • 7.1. 簡介 - 體溫
  • 7.2. 溫度傳感技術選項
  • 7.3. 醫用溫度傳感的方法和標準
  • 7.4. 用於溫度感應的皮膚貼片
  • 7.5。皮膚貼片溫度傳感:13 個案例研究中的用例
  • 7.6. VIV aLNK
  • 7.7. VivaLNK & Reckitt Benckiser
  • 7.8。VivaLNK:COVID-19 響應
  • 7.9。生物智能感知
  • 7.10。藍色火花
  • 7.11。Blue Spark & TempTraqR
  • 7.12。生命科學技術
  • 7.13。Isansys 生活護理
  • 7.14。瑞英醫療
  • 7.15。邦布頓
  • 7.16。CSEM
  • 7.17。科思創
  • 7.18。崔斯科技
  • 7.19。替代選項:鼓室溫度感應
  • 7.20。主要結論:感溫皮膚貼片

8. 電氣STIMULATIO NWITH皮膚貼劑

  • 8.1.1. 簡介:電刺激的類型
  • 8.1.2. 電刺激的分化
  • 8.1.3. 電刺激術語
  • 8.1.4. 電刺激產品類型
  • 8 .1.5。醫療與非醫療設備
  • 8.1.6。生物電子醫學:定義和背景
  • 8.1.7。生物電子醫學的主要形式
  • 8.1.8。生物電子醫學的演變
  • 8.1.9。生物電子醫學中的皮膚貼片
  • 8.2. 十
    • 8.2.1. TENS - 簡介
    • 8.2.2. 創新健康解決方案:NSS-2 Bridge
    • 8.2.3. BeWellConnect:MyTens
    • 8.2.4. NeuroMetrix:Quell
    • 8.2.5. Theranica: Nerivio Migra
  • 8.3. EMS/NME S/FES
    • 8.3.1. EMS、NMES 和 FES
    • 8.3.2. EMS/NMES 的應用
    • 8.3.3. 示例:俄羅斯刺激
    • 8.3.4. 示例:治療設置和用途
    • 8.3.5. 刺激的特性(如治療重點所示)
    • 8.3.6. 第一類醫學:geko
    • 8.3.7。示例:HiDow
    • 8.3.8。示例:HiDow
    • 8.3.9. 海沃生物科技
  • 8.4. 市場數據和預測
    • 8.4.1. 通過皮膚貼片進行電刺激:市場數據(2010-2019)
    • 8.4.2. 通過皮膚貼片進行電刺激:市場預測(2021-2031)

9. 離子電滲療法皮膚貼片:化妝品和藥物遞送

  • 9.1.1. 簡介 - 離子電滲療法
  • 9.1.2. c osmetics
  • 9.1.3. 化妝品皮膚貼片
  • 9.1.4. 雅詩蘭黛
  • 9.1.5。BioBliss□, Iontera, Patchology
  • 9.1.6。FeeliGreen (Feeligold)
  • 9.2. 藥物輸送
    • 9.2.1. 用於藥物遞送的離子電滲療法
    • 9.2.2 . 用於離子電滲療法的藥物研究
    • 9.2.3. 藥物輸送貼片的商業活動
    • 9.2.4. FeeliGreen (Feelicare)
    • 9.2.5。首爾國立大學:通過皮膚貼片治療帕金森病
  • 9.3. 反向離子電滲療法
    • 9.3.1. 反向離子導入
    • 9.3.2. 示例:GlucoWatch
    • 9.3.3. Nemaura Medical:sugarBEAT
  • 9.4. 市場預測和結論
    • 9.4.1. 通過皮膚貼片進行離子導入:市場數據(20 10-2019)
    • 9.4.2. 通過皮膚貼片進行離子導入:市場預測(2020-2030)
    • 9.4.3. 主要結論:離子電滲療法

10。汗液傳感:汗液率和生物標誌物

  • 10.1.1. 簡介 - 汗液感應
  • 10.2. 測量出汗率
    • 10.2.1. 技術概述 - 測量生物阻抗
    • 10.2.2. 技術概述 - 皮膚電反應 (GSR)
    • 10.2.3. 技術概覽 - 汗液濕度傳感器
    • 10.2.4. GE全球研究
  • 10.3. 檢測汗液中的生物標誌物
    • 10.3.1. 技術概述 - 汗液中的化學傳感
    • 10.3.2. 汗液與其他分析物來源
    • 10.3.3. 汗液中的分析物
    • 10.3.4. 使用化學傳感器進行診斷
    • 10.3.5。使用生物傳感器監測血液膽固醇
    • 10.3.6。邁向可穿戴膽固醇監測
    • 10.3.7。示例:汗液酒精檢測
    • 10.3.8。運動員乳酸監測
    • 10.3.9。傳統的乳酸監測儀
    • 10.3.10。微針分析組織間液中的乳酸
    • 10.3.11。越來越便攜的牛和人結核病診斷
    • 10.3.12。囊性纖維化的可穿戴診斷測試
    • 10.3.13。技術概述:化學傳感
    • 10.3.14。百聯
    • 10.3.15。肯岑
    • 10.3.16。米洛傳感器
    • 10.3.17。帕克/加州大學聖地亞哥分校
    • 10.3.18。斯坦福大學和加州大學伯克利分校
    • 10.3.19。森西奧
    • 10.3.20。Epicore生物系統公司
    • 10.3.21。外泌系統(關閉)
    • 10.3.22。主要結論:汗液感應

11。使用皮膚貼片進行傷口監測和治療

  • 11.1. 傷口監測
  • 11.2. 傷口監測:KAUST
  • 11.3. 傷口監測:普渡大學
  • 11.4. 傷口監測:塔夫茨大學
  • 11.5。傷口監測:廷德爾國立研究所
  • 11.6. 傷口監測:加州大學伯克利分校
  • 11.7. 傷口監測:UCSD
  • 11.8。傷口監測:VTT
  • 11.9。傷口Treatm ENT

12。帶有皮膚貼片的運動感應

  • 12.1.1. 簡介 - 通過皮膚貼片監測運動
  • 12.1.2. 感應運動的不同模式
  • 12.2. 使用慣性測量單元測量運動
    • 1 2.2.1. 介紹 - 慣性測量單元
    • 12.2.2. 使用 IMU 測量運動:示例
    • 12.2.3. 價值鍊和參與者示例
    • 12.2.4. 皮膚貼片中的 IMU
  • 12.3. 使用共形傳感器測量運動 < ul>
  • 12.3.1. 介紹 - 測量運動的替代方案
  • 12.3.2. 技術概述 - 電阻/壓阻傳感
  • 12.3.3. 參與者和行業動態
  • 12.3.4. 佩拉泰克
  • 12.3.5。量子隧穿複合材料:QTCR
  • 12.3.6。QTCR 與 FSR□ 與壓敏電阻器?
  • 12.3.7。Bebop 傳感器
  • 12.3.8。白尼莎
  • 12.3.9。技術概覽 - 電容式傳感
  • 12.3.10。派克漢尼汾
  • 12.3.11。拉伸感
  • 12.3. 12.飛躍科技
  • 12.3.13。技術概覽 - 壓電傳感
  • 12.4. 應用實例
    • 12.4.1. 皮膚貼片運動傳感器的應用
    • 12.4.2. 案例研究 - 腦震盪檢測
    • 12.4.3. X2生物系統
    • 12.4.4. 美國軍用頭部外傷貼片/PARC
    • 12.4.5。主要結論:運動傳感

    13。皮膚貼片作為植入物的通信網關

    • 13.1.1. 與植入物的交流
    • 13.2 . 糖尿病管理示例
      • 13.2.1. 感覺學
      • 13.2.2. Senseonics:皮膚貼片的作用
    • 13.3. 生物電子醫學中的例子
      • 13.3.1. 帶有生物電子醫學植入物的皮膚貼片
      • 13.3.2. 神經恢復技術
      • 13.3.3. Stimwave:自由 SCS
      • 13.3.4. SPR 療法:Sprint PNS
      • 13.3.5。生化:StimRouter
    • 13.4. 其他例子
      • 13.4.1. Proteus 數字健康
      • 13.4. 2. GraftWorx

    14。皮膚貼片的其他應用

    • 14.1. 壓瘡預防
      • 14.1.1. Leaf Healthcare(史密斯和侄子)
    • 14.2. 膀胱容積感應(可穿戴超聲波)
      • 14.2.1. 新掃瞄儀
      • 14.2.2. 三重 W - D 免費
    • 14.3. 其他保健和醫療應用
      • 14.3.1. 聲呼吸率(Acurable、Masimo 等)
      • 14.3.2. 紫外線防護
      • 14.3.3. MC10 & 歐萊雅:Wisp
      • 14.3.4. 救治:壓力管理
    • 14.4. 其他
      • 14.4.1. EOG - 帶有皮膚貼片的眼動追蹤

    15。市場預測

    • 15.1.1. 預測細節和假設
    • 15.2. 糖尿病管理預測
      • 15.2.1. 皮膚斑塊和糖尿病:預測摘要
      • 15.2.2. 概述:2020 年 CGM 市場份額和參與者
      • 15.2.3. 糖尿病管理的重點轉移,歷史數據:2010-2020
      • 15.2.4. 歷史市場數據:葡萄糖試紙
      • 15.2.5。歷史市場數據:CGM
      • 15.2.6。歷史市場數據:胰島素泵
      • 15.2.7。歷史市場數據:貼片泵
      • 15.2.8。糖尿病和CGM 的定量預測
      • 15.2.9。構建自上而下的預測場景
      • 15.2.10。市場數據和預測:葡萄糖試紙
      • 15.2.11。市場數據及預測:CGM(銷量)
      • 15.2.12。市場數據和預測:胰島素泵(收入) <我>15.2.13。市場數據及預測:胰島素泵(銷量)
      • 15.2.14。完整數據集:糖尿病管理中的皮膚斑塊,2010-2020(歷史)和 2021-2031(預測)
      • 15.2.15。完整數據集:糖尿病管理市場,2010-2020(歷史)和 2021-2031(預測)
    • 15.3. 心血管監測預測
      • 15.3.1. 市場概況和預測
      • 15.3.2. 心臟監測皮膚貼片:歷史數據:2010-2020
      • 15.3.3. 心臟監測皮膚補丁:市場預測
      • 15.3.4. 帶錶的完整數據集:2010-2019(歷史)和 2020-2030(預測)
    • 15.4. 一般患者監測預測
      • 15.4.1. 歷史市場數據,2010-2020
      • 15.4.2. 2021-2031 年市場預測
      • 15.4.3. 無線住院監護的市場數據和預測
      • 15.4.4. 無線門診監測的市場數據和預測
      • 15.4.5。胎心率監測預測
    • 15.5。電刺激預測
      • 15.5.1. 通過皮膚貼片進行電刺激:市場數據(2010-2019)
      • 15.5.2. 通過皮膚貼片進行電刺激:市場預測(2021-2031)
    • 15.6。溫度傳感預測
      • 15 .6.1。溫度傳感:市場數據和預測
    • 15.7。離子電滲療法預測
      • 15.7.1. 通過皮膚貼片進行離子導入:市場數據(2010-2019)
      • 15.7.2. 通過皮膚貼片進行離子導入:市場預測(2020-2030)
    • 15.8。所有行業的完整歷史和預測數據表
      • 15.8.1。按皮膚貼片產品類型劃分的收入(/百萬美元)
      • 15.8.2. 按皮膚貼片產品類型定價(/美元)
      • 15.8.3. 按皮膚貼片產品類型劃分的收入(/百萬美元)

    16。121 款電子皮膚貼片產品和播放器列表

    • 16.1. 公司簡介和採訪清單
  • 目錄
    Product Code: ISBN 9781913899523

    Title:
    Electronic Skin Patches 2021-2031
    The most comprehensive assessment on the commercialization of flexible, wearable, smart skin patches.

    "The market for electronic skin patches will be worth over $30bn per year by 2031."

    This report characterizes the markets, technologies and players in electronic skin patches. With coverage across 28 application areas and 127 companies, historic market data from 2010-2020 and market forecasts from 2021 to 2031, it is the most comprehensive study compiled for this product area. It reveals significant opportunity, with the sector passing $10bn in annual revenue from electronic skin patches in 2021, and a forecast for this to grow to over $30bn by 2031.

    Skin patches are wearable products attached to the skin. The electronic element involves the integration of electronic functionality such as sensors, actuators, processors and communication, allowing products to become connected and "smart". In many ways, skin patches act as the ultimate wearable electronic devices, augmenting the wearer with minimal encumbrance and maximum comfort. As such, interest in electronic skin patches soared as a by-product of the significant hype and market growth around "wearables" starting in 2014.

    However, several product types within the sector transcend this hype. Several skin patch product areas, particularly in diabetes management, cardiovascular monitoring, and other vital sign monitoring, have superseded incumbent options in established markets to create billions of dollars of new revenue each year for the companies at the forefront of this wave. However, success is not ubiquitous; each market discussed within this report sits within a unique ecosystem, with different players, drivers, limitations and history to build on.

    As such, the report looks at each of the application areas for electronic skin patches in turn, discussing the relevant technology, product types, competitive landscape, industry players, pricing, historic revenue, and market forecasts. The areas covered include diabetes management, cardiovascular monitoring devices (MCT, Holter monitors, Event monitors, and related products), medical patient monitoring (both inpatient and outpatient), motion sensing, temperature sensing, drug and cosmetic delivery patches, electrical stimulation devices, emerging options towards smart wound care and more. The report contains historic revenue data for each of the product sectors studied back to 2010, including data by company for the larger sectors. The report also contains detailed market forecasting over 10 years for each of the key application areas.

    28 application areas discussed within the report
    Source IDTechEx

    The product category of "electronic skin patches" conceals a significant amount of diversity. Whilst many people may imagine skin patches to be thin, highly conformable devices that sit close to the skin, the reality is that many of the most successful products today are still relatively bulky devices. As such, each chapter within the report also contains a discussion of technology areas relevant to the future development of smart patches, particularly around areas such as flexible, stretchable and conformal electronic components. Development of these technologies will not only enable more products to be deployed as skin patches but will also improve the form factor of electronic skin patches that already exist. This is also covered extensively in IDTechEx's other work in topics such as flexible electronic, stretchable electronics, thin and flexible batteries, smart textiles and other related topics.

    The research behind the report has been compiled over several years by IDTechEx analysts. It follows existing coverage of areas such as wearable technology, flexible electronics, stretchable and conformal electronics, electronic textiles, advanced wound care, bioelectronics, sensors and other medical devices. The methodology involved a mixture of primary and secondary research, with a key focus on speaking to executives and scientists from companies developing commercial electronic skin patches. As such, the report compiles case studies of 127 companies and projects, each updated over time and compared within their appropriate product ecosystems.

    Source IDTechEx

    Unique position and experience behind the report

    IDTechEx is afforded a particularly unique position in covering this topic. The experienced analyst team builds on decades of experience covering emerging technology markets, and particularly areas, such as flexible electronics, which are central to electronic skin patches. This has been historically supported by IDTechEx's parallel activities in organising the leading industry conferences and exhibitions covering flexible and wearable electronics, as well as smaller events covering specific innovation trends such as for healthcare sensors or related areas. IDTechEx has the unique ability to curate a network in these topic areas, facilitating the reporting in this report.

    Analyst access from IDTechEx

    All report purchases include up to 30 minutes telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

    TABLE OF CONTENTS

    1. EXECUTIVE SUMMARY

    • 1.1. Executive introduction: Electronic skin patches
    • 1.2. Application overview
    • 1.3. Applications, market sizes and outlook
    • 1.4. The diabetes management ecosystem
    • 1.5. CGM leads the way
    • 1.6. Insulin pumps and patch pumps
    • 1.7. The outlook for diabetes management
    • 1.8. Monitoring the heart via skin patches
    • 1.9. Players and product types in cardiac monitoring
    • 1.10. Cardiac monitoring skin patches: Historic data: 2010-2020
    • 1.11. Cardiac monitoring skin patches: Market forecasts
    • 1.12. Application potential for general purpose devices
    • 1.13. Historic market data, 2010-2020
    • 1.14. Market forecasts, 2021-2031
    • 1.15. Skin patch temperature sensing: Use cases across 13 case studies
    • 1.16. Key conclusions: Temperature sensing skin patches
    • 1.17. Electrical stimulation product types
    • 1.18. Skin patches in bioelectronic medicine
    • 1.19. Electrical stimulation via skin patches: Market data (2010-2019)
    • 1.20. Electrical stimulation via skin patches: Market forecast (2021-2031)
    • 1.21. Iontophoresis via skin patches: Market data (2010-2019)
    • 1.22. Iontophoresis via skin patches: Market forecast (2020-2030)
    • 1.23. Key conclusions: Iontophoresis
    • 1.24. Examples of players from case studies

    2. INTRODUCTION

    • 2.1.1. The case for skin patches: Augmenting the human body
    • 2.1.2. The case for skin patches: Improving device form factor
    • 2.1.3. Definitions and exclusions
    • 2.1.4. History of skin patches
    • 2.1.5. Applications, market sizes and outlook
    • 2.1.6. Reimbursement drives commercial business models
    • 2.1.7. Patents: Total active patents by assignee
    • 2.1.8. Patents over time
    • 2.1.9. Patents: Active and strong patents by assignee
    • 2.1.10. Context: Wearables hype
    • 2.1.11. Glossary
    • 2.1.12. Glossary (continued)
    • 2.2. Application overview
      • 2.2.1. Skin patches competing with established products
      • 2.2.2. New market creation around skin patches
      • 2.2.3. Section contents

    3. DIABETES MANAGEMENT VIA SKIN PATCHES

    • 3.1.1. Background: Introduction to diabetes
    • 3.1.2. The prevalence of diabetes
    • 3.1.3. Background: Diabetes on the rise
    • 3.1.4. Background: The cost of diabetes
    • 3.1.5. Background: The diabetes management process
    • 3.1.6. Diabetes management ecosystem
    • 3.1.7. Diabetes management device roadmap: Summary
    • 3.1.8. Diabetes management device roadmap: Sensors
    • 3.1.9. Coverage in this report
    • 3.2. Continuous glucose monitoring (CGM)
      • 3.2.1. The case for continuous glucose monitoring (CGM)
      • 3.2.2. Anatomy of a typical CGM device
      • 3.2.3. CGM is deployed via skin patches
      • 3.2.4. Comparison metrics for CGM devices
      • 3.2.5. Example: Accuracy of CGM devices over time
      • 3.2.6. CGM: Technology
      • 3.2.7. CGM sensor chemistry
      • 3.2.8. Sensor filament structure
    • 3.3. CGM: Overview of key players
      • 3.3.1. CGM: Overview of key players
      • 3.3.2. Abbott Laboratories: Introduction
      • 3.3.3. Abbott Laboratories: CGM business
      • 3.3.4. Abbott: Freestyle® Libre
      • 3.3.5. Abbott: "Wired enzyme"
      • 3.3.6. Abbott: Device and sensor structure
      • 3.3.7. Dexcom: Introduction
      • 3.3.8. Dexcom: CGM products
      • 3.3.9. Dexcom: Sensor structure
      • 3.3.10. Medtronic: Introduction
      • 3.3.11. Medtronic: Diabetes & CGM business
      • 3.3.12. Medtronic: Sensor structure
      • 3.3.13. Medtronic: Towards closed loop
      • 3.3.14. Medtronic: Patents in CGM
      • 3.3.15. Roche: Overview
      • 3.3.16. Roche: Patents in CGM
      • 3.3.17. Senseonics
      • 3.3.18. Ascensia & POCTech
      • 3.3.19. Medtrum
      • 3.3.20. Medtrum: CGM devices & insulin pumps
      • 3.3.21. Medtrum: Sensing technology
      • 3.3.22. Medtrum: Specific development steps towards the artificial pancreas
      • 3.3.23. Medtrum
      • 3.3.24. AgaMatrix & WaveForm Technologies
      • 3.3.25. Infinovo
      • 3.3.26. PKVitality
      • 3.3.27. Sano
      • 3.3.28. Verily / Google: Contact lenses
    • 3.4. Non-invasive glucose monitoring
      • 3.4.1. Background: Glucose in the body
      • 3.4.2. Assessment of different analytes for glucose monitoring
      • 3.4.3. Key criteria for assessing accuracy
      • 3.4.4. In Context: FDA requirements
      • 3.4.5. Approaches for non-invasive glucose monitoring
      • 3.4.6. Companies Using Each Technique
      • 3.4.7. Companies Using Each Technique (Other Fluids)
      • 3.4.8. When will non-invasive glucose monitoring be commercialised?
      • 3.4.9. Notable Quotes on Non-Invasive Glucose Monitoring
    • 3.5. Insulin delivery
      • 3.5.1. Insulin delivery: Introduction
      • 3.5.2. Diabetes management device roadmap: Insulin delivery
      • 3.5.3. Insulin pumps: Introduction
      • 3.5.4. Insulin pumps currently available
      • 3.5.5. Insulin pump breakdown
      • 3.5.6. Insulin patch pumps
      • 3.5.7. Example: Patch pumps at Medtronic?
      • 3.5.8. Pricing models for patch pumps vs traditional options
      • 3.5.9. Insulin pump market
      • 3.5.10. Insulin pump players and market share
      • 3.5.11. Markets: Patch pumps vs traditional infusion pumps
      • 3.5.12. Comparing insulin pumps and CGM
      • 3.5.13. Outlook for insulin pumps
    • 3.6. Linking insulin pumps and CGM: Towards closed loop and the artificial pancreas
      • 3.6.1. Today: Hybrid closed loop systems
      • 3.6.2. Example: Progress from Medtronic
      • 3.6.3. The objective: Closing the feedback loop
      • 3.6.4. Examples and partnerships
      • 3.6.5. Example: DiabeLoop
      • 3.6.6. Medtrum: Efforts towards the artificial pancreas
    • 3.7. Market data: Historic & forecasts
      • 3.7.1. Skin patches and diabetes: Forecast summary
      • 3.7.2. Overview: CGM market share and players in 2020
      • 3.7.3. A shifting focus in diabetes management, Historic data: 2010-2020
      • 3.7.4. Test strip business in decline
      • 3.7.5. The growth of CGM accelerates
      • 3.7.6. The insulin pump market
      • 3.7.7. Markets: Patch pumps vs traditional infusion pumps
      • 3.7.8. Quantitative forecasts for diabetes and CGM
      • 3.7.9. Building a top-down forecast scenario
      • 3.7.10. CGM: Market forecast (revenue)
      • 3.7.11. CGM: Market forecast (sales volumes)
      • 3.7.12. Insulin pumps: Market forecast (revenue)
      • 3.7.13. Insulin pumps: Market forecast (sales volumes)
      • 3.7.14. Full datasets: Skin patches in diabetes management, 2010-2020 (historic) & 2021-2031 (forecast)
      • 3.7.15. Full datasets: Diabetes management markets, 2010-2020 (historic) & 2021-2031 (forecast)

    4. GENERAL PATIENT MONITORING: VITAL SIGNS AND RELATED METRICS

    • 4.1. Introduction
      • 4.1.1. Introduction
      • 4.1.2. Drivers and requirements for skin patches
      • 4.1.3. Application potential for general purpose devices
      • 4.1.4. Deployment challenges for general monitoring devices
      • 4.1.5. Evolving market dynamics over time
      • 4.1.6. General monitoring needs an infrastructure that only the larger players can provide
      • 4.1.7. Historic market data, 2010-2020
      • 4.1.8. Market forecasts, 2021-2031
    • 4.2. Inpatient monitoring
      • 4.2.1. Traditional inpatient monitoring
      • 4.2.2. The case for removing the wires
      • 4.2.3. Emerging skin patch options
      • 4.2.4. Players and approaches
      • 4.2.5. Philips
      • 4.2.6. BioIntelliSense
      • 4.2.7. VivaLNK
      • 4.2.8. The Surgical Company (formerly Sensium)
      • 4.2.9. VitalConnect
      • 4.2.10. Isansys Lifecare
      • 4.2.11. Market data and forecasts for wireless inpatient monitoring
    • 4.3. Outpatient monitoring with skin patches
      • 4.3.1. Introduction
      • 4.3.2. LifeSignals
      • 4.3.3. Samsung
      • 4.3.4. MC10
      • 4.3.5. DevInnova / Scaleo Medical
      • 4.3.6. Avanix
      • 4.3.7. Avanix - business model and target milestones
      • 4.3.8. Historic: Qualcomm Life
      • 4.3.9. Qualcomm Life / Capsule Technologies
      • 4.3.10. Market data and forecasts for wireless outpatient monitoring

    5. CARDIOVASCULAR MONITORING SKIN PATCHES

    • 5.1.1. Introduction - Cardiovascular monitoring via wearable devices
    • 5.1.2. Introduction - Measuring biopotential
    • 5.1.3. Technology overview - the circuitry for measuring biopotential
    • 5.1.4. Introduction - Electrocardiography (ECG, or EKG)
    • 5.1.5. Devices for cardiac monitoring
    • 5.1.6. Cardiac monitoring device types - skin patches
    • 5.1.7. Companies and product types
    • 5.1.8. Technology overview - electrode properties
    • 5.1.9. Disposable Ag/AgCl electrodes
    • 5.1.10. Electrodes: Traditional approaches
    • 5.1.11. Skin patches with disposable electrodes
    • 5.1.12. Skin patches with integrated electrodes
    • 5.2. Reimbursement
      • 5.2.1. Reimbursement codes for wearable cardiac monitors
      • 5.2.2. 2021: New reimbursement structure in place
      • 5.2.3. Fallout and outlook following the 2021 code change
    • 5.3. Players
      • 5.3.1. Summaries and interviews with 20 industry players
      • 5.3.2. Philips
      • 5.3.3. BioTelemetry, Inc.
      • 5.3.4. BioTelemetry: Timeline
      • 5.3.5. iRhythm
      • 5.3.6. ScottCare
      • 5.3.7. Fukuda Denshi
      • 5.3.8. Fujita Medical Instruments
      • 5.3.9. Bittium
      • 5.3.10. Byteflies & Quad Industries
      • 5.3.11. Cardiomo
      • 5.3.12. Vivomi
      • 5.3.13. QT Medical
      • 5.3.14. SWMedical
      • 5.3.15. SWMedical - CardiNova
      • 5.3.16. Seers Technology
      • 5.3.17. Rooti
      • 5.3.18. Preventice Solutions
      • 5.3.19. Sigknow
      • 5.3.20. Borsam
      • 5.3.21. Cortrium
      • 5.3.22. Qardio
      • 5.3.23. Qardio (2)
      • 5.3.24. Holst Center: Skin patches
      • 5.3.25. Tatch
      • 5.3.26. Mezoo
      • 5.3.27. S'UIMIN
      • 5.3.28. Medtronic: SEEQ MCT (discontinued)
      • 5.3.29. LumiraDx / FitLinxx: Ampstrip (discontinued)
    • 5.4. Competition with other form factors
      • 5.4.1. Other form factors for ambulatory cardiac monitoring
      • 5.4.2. Wearable vs implantable monitoring
      • 5.4.3. Example: Medtronic (SEEQ & LINQ)
      • 5.4.4. Comparison: Chest straps
      • 5.4.5. Comparison: Apparel
      • 5.4.6. Comparison: Portable devices
      • 5.4.7. Comparison: Smartwatch optical HRM
    • 5.5. Market data and forecasts
      • 5.5.1. Market overview and forecasts
      • 5.5.2. The impact of COVID-19
      • 5.5.3. Cardiac monitoring skin patches: Historic data: 2010-2020
      • 5.5.4. Cardiac monitoring skin patches: Market forecasts
      • 5.5.5. Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast)
      • 5.5.6. Key conclusions: cardiac monitoring skin patches

    6. FOETAL HEART RATE MONITORING

    • 6.1. Foetal monitoring
    • 6.2. Monica Healthcare
    • 6.3. GE Healthcare
    • 6.4. Philips
    • 6.5. Key conclusions and market data

    7. TEMPERATURE SENSING SKIN PATCHES

    • 7.1. Introduction - Body Temperature
    • 7.2. Temperature sensing technology options
    • 7.3. Approaches and standards for medical temperature sensing
    • 7.4. Skin patches for temperature sensing
    • 7.5. Skin patch temperature sensing: Use cases across 13 case studies
    • 7.6. VivaLNK
    • 7.7. VivaLNK & Reckitt Benckiser
    • 7.8. VivaLNK: COVID-19 response
    • 7.9. BioIntelliSense
    • 7.10. Blue Spark
    • 7.11. Blue Spark & TempTraq®
    • 7.12. Life Science Technology
    • 7.13. Isansys Lifecare
    • 7.14. Raiing Medical
    • 7.15. Bonbouton
    • 7.16. CSEM
    • 7.17. Covestro
    • 7.18. Chois Technology
    • 7.19. Alternative options: Tympanic temperature sensing
    • 7.20. Key conclusions: Temperature sensing skin patches

    8. ELECTRICAL STIMULATION WITH SKIN PATCHES

    • 8.1.1. Introduction: Types of electrical stimulation
    • 8.1.2. Differentiation for electrical stimulation
    • 8.1.3. Nomenclature in electrical stimulation
    • 8.1.4. Electrical stimulation product types
    • 8.1.5. Medical vs non-medical devices
    • 8.1.6. Bioelectronic Medicine: Definition and background
    • 8.1.7. Major Forms of Bioelectronic Medicine
    • 8.1.8. The Evolution of Bioelectronic Medicine
    • 8.1.9. Skin patches in bioelectronic medicine
    • 8.2. TENS
      • 8.2.1. TENS - Introduction
      • 8.2.2. Innovative Health Solutions: NSS-2 Bridge
      • 8.2.3. BeWellConnect: MyTens
      • 8.2.4. NeuroMetrix: Quell
      • 8.2.5. Theranica: Nerivio Migra
    • 8.3. EMS / NMES / FES
      • 8.3.1. EMS, NMES and FES
      • 8.3.2. Applications of EMS / NMES
      • 8.3.3. Example: Russian Stimulation
      • 8.3.4. Example: Therapeutic settings and uses
      • 8.3.5. Properties of the stimulation (as presented with a therapeutic focus)
      • 8.3.6. First Kind Medical: geko
      • 8.3.7. Example: HiDow
      • 8.3.8. Example: HiDow
      • 8.3.9. Hivox Biotek
    • 8.4. Market data and forecasts
      • 8.4.1. Electrical stimulation via skin patches: Market data (2010-2019)
      • 8.4.2. Electrical stimulation via skin patches: Market forecast (2021-2031)

    9. IONTOPHORESIS SKIN PATCHES: COSMETICS AND DRUG DELIVERY

    • 9.1.1. Introduction - Iontophoresis
    • 9.1.2. Cosmetics
    • 9.1.3. Cosmetic skin patches
    • 9.1.4. Estée Lauder
    • 9.1.5. BioBliss™, Iontera, Patchology
    • 9.1.6. FeeliGreen (Feeligold)
    • 9.2. Drug delivery
      • 9.2.1. Iontophoresis for drug delivery
      • 9.2.2. Drugs studied for iontophoretic delivery
      • 9.2.3. Commercial activity with drug delivery patches
      • 9.2.4. FeeliGreen (Feelicare)
      • 9.2.5. Seoul National University: Parkinson's medication via skin patches
    • 9.3. Reverse iontophoresis
      • 9.3.1. Reverse Iontophoresis
      • 9.3.2. Example: GlucoWatch
      • 9.3.3. Nemaura Medical: sugarBEAT
    • 9.4. Market forecasts and conclusions
      • 9.4.1. Iontophoresis via skin patches: Market data (2010-2019)
      • 9.4.2. Iontophoresis via skin patches: Market forecast (2020-2030)
      • 9.4.3. Key conclusions: Iontophoresis

    10. SWEAT SENSING: SWEAT RATE AND BIOMARKERS

    • 10.1.1. Introduction - Sweat sensing
    • 10.2. Measuring sweat rate
      • 10.2.1. Technology overview - measuring bioimpedance
      • 10.2.2. Technology overview - Galvanic skin response (GSR)
      • 10.2.3. Technology overview - humidity sensors for sweat
      • 10.2.4. GE Global Research
    • 10.3. Sensing biomarkers in sweat
      • 10.3.1. Technology overview - chemical sensing in sweat
      • 10.3.2. Sweat vs other sources of analytes
      • 10.3.3. Analytes in sweat
      • 10.3.4. Diagnostics with chemical sensors
      • 10.3.5. Monitoring blood cholesterol using biosensors
      • 10.3.6. Towards wearable cholesterol monitoring
      • 10.3.7. Example: sweat alcohol detection
      • 10.3.8. Lactic acid monitoring for athletes
      • 10.3.9. Traditional lactic acid monitors
      • 10.3.10. Microneedles to analyse lactic acid in interstitial fluid
      • 10.3.11. Increasingly portable diagnosis of bovine and human TB
      • 10.3.12. Wearable diagnostic tests for cystic fibrosis
      • 10.3.13. Technology overview: Chemical sensing
      • 10.3.14. Biolinq
      • 10.3.15. Kenzen
      • 10.3.16. Milo Sensors
      • 10.3.17. PARC / UCSD
      • 10.3.18. Stanford and UC Berkeley
      • 10.3.19. Xsensio
      • 10.3.20. Epicore Biosystems
      • 10.3.21. Eccrine Systems (closed)
      • 10.3.22. Key conclusions: Sweat sensing

    11. WOUND MONITORING AND TREATMENT WITH SKIN PATCHES

    • 11.1. Wound Monitoring
    • 11.2. Wound Monitoring: KAUST
    • 11.3. Wound Monitoring: Purdue University
    • 11.4. Wound Monitoring: Tufts University
    • 11.5. Wound Monitoring: Tyndall National Institute
    • 11.6. Wound Monitoring: UC Berkeley
    • 11.7. Wound Monitoring: UCSD
    • 11.8. Wound Monitoring: VTT
    • 11.9. Wound Treatment

    12. MOTION SENSING WITH SKIN PATCHES

    • 12.1.1. Introduction - Monitoring motion via skin patches
    • 12.1.2. Different modes for sensing motion
    • 12.2. Measuring motion with inertial measurement units
      • 12.2.1. Introduction - Inertial measurement units
      • 12.2.2. Measuring motion with IMUs: Examples
      • 12.2.3. Value chain and examples of players
      • 12.2.4. IMUs in skin patches
    • 12.3. Measuring motion with conformal sensors
      • 12.3.1. Introduction - alternatives for measuring motion
      • 12.3.2. Technology overview - Resistive/piezoresistive sensing
      • 12.3.3. Players and industry dynamic
      • 12.3.4. Peratech
      • 12.3.5. Quantum tunnelling composite: QTC®
      • 12.3.6. QTC® vs. FSR™ vs. piezoresistor?
      • 12.3.7. Bebop Sensors
      • 12.3.8. Bainisha
      • 12.3.9. Technology overview - Capacitive sensing
      • 12.3.10. Parker Hannifin
      • 12.3.11. Stretchsense
      • 12.3.12. LEAP Technology
      • 12.3.13. Technology overview - Piezoelectric sensing
    • 12.4. Application examples
      • 12.4.1. Applications for skin patch motion sensors
      • 12.4.2. Case study - Concussion detection
      • 12.4.3. X2 Biosystems
      • 12.4.4. US Military head trauma patch / PARC
      • 12.4.5. Key conclusions: Motion sensing

    13. SKIN PATCHES AS A COMMUNICATION GATEWAY TO IMPLANTS

    • 13.1.1. Communication with implants
    • 13.2. Examples in diabetes management
      • 13.2.1. Senseonics
      • 13.2.2. Senseonics: The role of the skin patch
    • 13.3. Examples in bioelectronic medicine
      • 13.3.1. Skin patches with bioelectronic medicine implants
      • 13.3.2. NeuroRecovery Technologies
      • 13.3.3. Stimwave: Freedom SCS
      • 13.3.4. SPR Therapeutics: Sprint PNS
      • 13.3.5. Bioness: StimRouter
    • 13.4. Other examples
      • 13.4.1. Proteus Digital Health
      • 13.4.2. GraftWorx

    14. OTHER APPLICATIONS OF SKIN PATCHES

    • 14.1. Pressure ulcer prevention
      • 14.1.1. Leaf Healthcare (Smith & Nephew)
    • 14.2. Bladder volume sensing (wearable ultrasound)
      • 14.2.1. Novioscan
      • 14.2.2. Triple W - D Free
    • 14.3. Other healthcare & medical applications
      • 14.3.1. Acoustic respiration rate (Acurable, Masimo, etc.)
      • 14.3.2. UV protection
      • 14.3.3. MC10 & L'Oréal: Wisp
      • 14.3.4. Lief Therapeutics: Stress Management
    • 14.4. Others
      • 14.4.1. EOG - eye tracking with skin patches

    15. MARKET FORECASTS

    • 15.1.1. Forecast details and assumptions
    • 15.2. Diabetes management forecasts
      • 15.2.1. Skin patches and diabetes: Forecast summary
      • 15.2.2. Overview: CGM market share and players in 2020
      • 15.2.3. A shifting focus in diabetes management, Historic data: 2010-2020
      • 15.2.4. Historic market data: Glucose test strips
      • 15.2.5. Historic market data: CGM
      • 15.2.6. Historic market data: Insulin pumps
      • 15.2.7. Historic market data: Patch pumps
      • 15.2.8. Quantitative forecasts for diabetes and CGM
      • 15.2.9. Building a top-down forecast scenario
      • 15.2.10. Market data and forecast: Glucose test strips
      • 15.2.11. Market data and forecast: CGM (sales volume)
      • 15.2.12. Market data and forecast: Insulin pumps (revenue)
      • 15.2.13. Market data and forecast: Insulin pumps (sales volume)
      • 15.2.14. Full datasets: Skin patches in diabetes management, 2010-2020 (historic) & 2021-2031 (forecast)
      • 15.2.15. Full datasets: Diabetes management markets, 2010-2020 (historic) & 2021-2031 (forecast)
    • 15.3. Cardiovascular monitoring forecasts
      • 15.3.1. Market overview and forecasts
      • 15.3.2. Cardiac monitoring skin patches: Historic data: 2010-2020
      • 15.3.3. Cardiac monitoring skin patches: Market forecasts
      • 15.3.4. Full dataset with table: 2010-2019 (historic) & 2020-2030 (forecast)
    • 15.4. General patient monitoring forecasts
      • 15.4.1. Historic market data, 2010-2020
      • 15.4.2. Market forecasts, 2021-2031
      • 15.4.3. Market data and forecasts for wireless inpatient monitoring
      • 15.4.4. Market data and forecasts for wireless outpatient monitoring
      • 15.4.5. Foetal heart rate monitor forecasts
    • 15.5. Electrical stimulation forecasts
      • 15.5.1. Electrical stimulation via skin patches: Market data (2010-2019)
      • 15.5.2. Electrical stimulation via skin patches: Market forecast (2021-2031)
    • 15.6. Temperature sensing forecasts
      • 15.6.1. Temperature sensing: Market data and forecasts
    • 15.7. Iontophoresis forecasts
      • 15.7.1. Iontophoresis via skin patches: Market data (2010-2019)
      • 15.7.2. Iontophoresis via skin patches: Market forecast (2020-2030)
    • 15.8. Full historic and forecast data tables for all sectors
      • 15.8.1. Revenue by skin patch product type (/USD millions)
      • 15.8.2. Pricing by skin patch product type (/USD)
      • 15.8.3. Revenue by skin patch product type (/USD millions)

    16. LIST OF 121 ELECTRONIC SKIN PATCH PRODUCTS AND PLAYERS

    • 16.1. List of company profiles and interviews